Skip to content

Increasing Vaccine Uptake in Underresourced Public Housing Areas

Community Partnered Intervention to Increase COVID-19 Vaccine Uptake in Low Income Underresourced African Americans and Latinx Public Housing Residents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04779138
Enrollment
462
Registered
2021-03-03
Start date
2021-09-11
Completion date
2024-04-01
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus, Vaccine Refusal

Brief summary

This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to provide education at multiple levels and implement innovate strategies to engage this population in the uptake of COVID-19 vaccination.

Detailed description

One particular group, African American and Latinx public housing residents, are facing adverse effects related to worsening social determinants and health disparities. Utilizing a community-driven approach, the overall objective of this proposed study is to increase COVID-19 vaccine uptake and completion the impact of COVID-19 among African American and Latinx public housing residents. Guided by the Community Based Participatory Model, the Information, Motivation, and Behavioral Skills (IMB) and the Transtheoretical Model will be utilized to carry out this intervention. Through this innovative program, we will establish Academic-Community Team for Improving Vaccine Acceptability and Targeted Engagement (ACTIVATE) program, which will develop leadership triads of public housing resident leaders, nurse practitioner students, and public health students to carry out this multilevel intervention.

Interventions

BEHAVIORALIncreasing Willingness and Uptake of COVID-19 Vaccination

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 vaccine hesitancy and increase willingness and uptake in COVID-19 vaccination.

Sponsors

Charles Drew University of Medicine and Science
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Aim 2: Inclusion Criteria: * identify as Latinx or African American * age 18 or older * reside in one of the six collaborating public housing area * Speak either English or Spanish

Exclusion criteria

* Not a resident at one of the collaborating public housing areas * Does not self-identify as African American or Latinx * Age 17 and younger * Unable to speak either English or Spanish Aim 3: Inclusion Criteria: * identify as Latinx or African American * age 18 or older * reside in one of the six collaborating public housing area * Speak either English or Spanish * Report vaccine hesitancy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self ReportIntervention: 4 months; Follow-up Point: 3 months post-intervention1\. By comparison of pre-, post- intervention, and 9- and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in completion of COVID-19 vaccination series

Secondary

MeasureTime frameDescription
Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19 vaccine Using the NIH Toolbox Surveys on COVID-19Intervention: 4 months; Follow-up Point: 3 months post-intervention1\. By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in hesitancy toward COVID-19 vaccination.
Percentage of Participants Achieving Increased Level of Behavior Change toward COVID-19 Vaccination Using the NIH Toolbox Surveys on COVID-19Intervention: 4 months; Follow-up Point: 3 months post-intervention2\. By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in their behavior stage of change toward COVID-19 vaccination

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026